2021•PubMedRequires access

[Effect of metformin and rosiglitazone in non-obese polycystic ovary syndrome women with insulin resistance].

Jindong Tan, Gabriella Zhou, Q Y Wang, T T Liu, Qi Cao, Wei Huang

Abstract

For non-obese PCOS insulin resistance patients, screening of anthropometric and metabolic parameters is necessary. For PCOS with insulin resistance, lifestyle plus insulin sensitizers such as metformin could improve their clinical symptoms, correct the biochemical and metabolic dysfunction.

About this research paper

What this paper is about

Why it matters

OpenAlex reports 3 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Rosiglitazone, Metformin, Insulin resistance, Polycystic ovary, Medicine, Internal medicine, Endocrinology, Insulin